Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Open: Feb 9, 11:45 AM 2012 
  NYSE  8068.15  14.83  Index Moved Down   NASDAQ  2916.32  0.46  Index Moved Up 
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for HSP...
33.94
  
Hospira Quote
Intraday
 
Hospira Intraday Quote
One Month
(0.81)  Macroaxis: -2.33 Down   2.33%  
 26.92 Year To Date 59.2 
 33.71 Trading Day  34.76 
    
Diversification Suggestion
Use Hospira to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals
1 Month Beta vs NYSE ......... 0.01
As returns on NYSE increase, Hospira returns are expected to increase less then the market. However, during bear market, the loss on holding Hospira will be expected to be smaller as well
Hospira Small Beta
    
HSP Macroaxis: United States NYSEHospira Quote: Bear
Hospira Inc
http://www.hospira.com
224-212-2000
Trade Hospira
Run Report
 Run Report 
Correlation
 Correlation 
Drug Delivery  
Market Capitalization 5.590B  
Earnings Per Share 1.571  
Today Lowest 33.71  
Book Value Per Share 19.359  
 John C. Staley  executive  John C. Staley
Chairman, Member of Governance & 
 Thomas E. Werner  executive  Thomas E. Werner
Chief Financial Officer and Sr. VP  
 Ron  Squarer Bsc (biochemistry)mba executive  Ron Squarer Bsc (biochemistry)mba
Chief Commercial Officer and Sr. VP 
Dr. Sumant  Ramachandra M.D., Ph.D. executive Dr. Sumant Ramachandra M.D., Ph.D.
Chief Scientific Officer and Sr. VP 
 James H. Hardy Jr. executive  James H. Hardy Jr.
Sr. VP of Operations 

Hospira fundamentals

    
P/E22.12Open34.70
P/B Ratio1.80Volume873082
SectorHealthcareLast Close34.75
Short Ratio2.80Last Traded2/9/2012
Year High59.20Percent ChangePrice Moved Very Down 2.33%
Year Low26.92Absolute Change0.81 Price Moved Down
EPS1.571Index MembershipNot Applicable
PEG Ratio2.57Employees14,000
Day High34.76Day Low33.71
Target Price32.92Current EPS1.571
This Year EPS2.99Next Year EPS2.43
Current PE22.12This Year PE11.62
Next Year PE14.30DividendNot Applicable
    

Hospira Performance    Embed Financials for Hospira Inc

    
    
 Embed Financials for Hospira Inc

Hospira Profile

    
Hospira, Inc., a specialty pharmaceutical and medication delivery company, that develops, manufactures, and markets products that help improve the safety and productivity of patient care.
 Macroaxis: United States IXIC   0.02 % Macroaxis: 0.02 Moved Up  
 
 Macroaxis: United States GSPC   0.17 % Macroaxis: 0.17 Moved Down  
 
 Macroaxis: United States NYA   0.18 % Macroaxis: 0.18 Moved Down  
 
 Macroaxis: thisRed HSP   2.33 % Macroaxis: change 2.33 Moved Down  
 
 Live Sentiment  
 Bulls THRX 
 NGM Macroaxis: United States 
 Bought over 100 shares of
 25 minutes ago
for 17.9 
 Bulls XOMA 
 NGM Macroaxis: United States 
 Bought over 100 shares of
 25 minutes ago
for 1.58 
 Bulls MEMS 
 NGM Macroaxis: United States 
 Bought over 500 shares of
 41 minutes ago
for 3.02 
 Bulls TUNE 
 N/A Macroaxis: United States 
 Bought over 500 shares of
 41 minutes ago
for 2.92 
 Bulls STAA 
 NGM Macroaxis: United States 
 Bought over 100 shares of
 41 minutes ago
for 10.97 
    

Hospira 30-Days Moving Rating

    

Macroaxis Total Score 

    
10
Current 30 Days Moving Rating
    
    

Estimated Market Risk

 1.75
  actual daily
 
 71 %
of total potential
 
Market Risk score

Expected Return

 0.56
  actual daily
 
 44 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.32
  actual daily
 
 20 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average   [ change ] 
Increase Risk-Adjusted return of HSP by adding it to a well-diversified portfolio
    

 Hospira Last Intraday

    
 
(0.81)Macroaxis: -0.81 Up2.33%
 
34.75,34.75,33.94,33.94,34.76,33.71,33.94
 
34.7533.94
    

Latest headlines for Hospira


Investor in NYSE:HSP Shares Files Lawsuit Against Hospira, Inc. Directors

A lawsuit was filed by a current investor in HSP shares over alleged breaches of fiduciary duty by certain directors at Hospira, Inc. San Diego, CA -- (SBWIRE) -- 01/26/2012 -- The Shareholders Foundation announces that an investor in NYSE: HSP shares ...

HOSPIRA, INC.: Hospira named a Top 50 Organization for Multicultural Busin..

(NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, announced today it has been named as one of the , the largest organization representing diversity-owned businesses throughout the United States.

Hospira (HSP) Share Price Target Increased to $38.00 by Analysts at Bank of ...

Hospira (HSP) Share Price Target Increased to $38.00 by Analysts at Bank of ... LocalizedUSA - 20 hours ago Bank of America (NYSE: BAC) raised their price target on shares of Hospira (NYSE: HSP) to $38.00 in a research note issued on Tuesday.

Analysts' Downgrades for January, 10th (ADC, ALTH, CNW, DB, DRI, EQY, HSP, KEY ...

Analysts' Downgrades for January, 10th (ADC, ALTH, CNW, DB, DRI, EQY, HSP, KEY ... LocalizedUSA - 4 hours ago Agree Realty Corp (NYSE: ADC) was downgraded by analysts at Raymond James to an ?outperform? rating. Allos Therapeutics Incorporated (NASDAQ: ALTH) was downgraded by analysts at Zacks Investment Research from an ?outperform? rating to a ?neutral? ...

Hospira (HSP) Shares Downgraded by Raymond James (RJF) to "Market Perform"

Hospira (NYSE: HSP) was downgraded by equities research analysts at Raymond James (NYSE: RJF) from an ?outperform? rating to a ?market perform? rating in a research note issued to investors on Tuesday.